Showing results (391-400 of 498) with videos related to

Sort By:
Pageof 50
Nature Communications|July 11, 2020
Comprehensive characterization of claudin-low breast tumors reflects the impact of the cell-of-origin on cancer evolutionRoxane M Pommier, Amélien Sanlaville, Laurie Tonon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trialsDavid Sibon, Marion Fournier, Josette Brière, et al.
Oncoimmunology|May 4, 2016
A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavageColette Dezutter-Dambuyant, Isabelle Durand, Laurent Alberti, et al.
JACC. Cardiooncology|September 12, 2025
Diagnostic Performance of the New Free Light Chain Ratio in Systemic AmyloidosisPaolo Milani, Giuseppe Damiano Sanna, Claudia Bellofiore, et al.
Blood|April 4, 2020
Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDAGiovanni Palladini, Efstathios Kastritis, Mathew S Maurer, et al.
Orphanet Journal of Rare Diseases|April 8, 2021
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in ItalyLorenza Magliano, Laura Obici, Claudia Sforzini, et al.
Hematological Oncology|June 2, 2024
A real-life study of daratumumab combinations in newly diagnosed patients with light chain (AL) amyloidosisClaudia Bellofiore, Pietro Benvenuti, Roberto Mina, et al.
American Journal of Hematology|August 11, 2016
N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myelomaPaolo Milani, S Vincent Rajkumar, Giampaolo Merlini, et al.
Pageof 50